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1. Introduction 
Purified preparations of glycogen synthase 
(EC 2.4.1.11) have been shown to be contaminated 
with two types of protein kinase that phosphorylate 
the enzyme. One of these kinases was cyclic AMP- 
dependent protein kinase (EC 2.7.1.37), while the 
other was an activity termed glycogen synthase 
kinase-2. The latter enzyme could be distinguished 
from cyclic AMP-dependent protein kinase in a 
number of ways. Its activity was unaffected by 
cyclic AMP or by the specific protein inhibitor of 
cyclic AMP-dependent protein kinase, it had a higher 
Km for ATP, and a different nucleoside triphosphate 
specificity [ 11. 
Following digestion of the native enzyme with 
trypsin, the sites phosphorylated by cyclic AMP- 
dependent protein kinase were found to be released 
much more rapidly than those phosphorylated by 
glycogen synthase kinase-2, and this suggested that 
the two kinases phosphorylated different sites on the 
enzyme [ 11. The amino acid sequences at the two 
sites phosphorylated by cyclic AMP-dependent 
protein kinase have been determined [2-41. In this 
paper, we show that the endogenous glycogen synthase 
kinase-2 activity, preferentially phosphorylates a 
serine residue distinct from either of the sites labelled 
by cyclic AMP-dependent protein kinase. In conjunc- 
tion with the information presented in [4], it is con- 
cluded that this serine is located seven residues from 
the N-terminus of the polypeptide chain. 
2. Materials and methods 
Glycogen synthase a was purified to near 
homogeneity [5] following modifications described 
in [6]. The protein inhibitor of cyclic AMP-dependent 
protein kinase was partially purified as a byproduct 
of the preparation of protein phosphatase inhibitor-l 
[7]. The phosphorylation of glycogen synthase by 
endogenous glycogen synthase kinase-2, was carried 
out at 25’C, pH 7.0 in the following incubation: 
glycogen synthase 1 .O mg/ml, sodium glycerophosphate 
10.0 mM, EDTA 0.4 mM, ethylene glycol bis 
(2 aminoethylether) NJ’ tetracetic acid 0.1 mM, 
protein kinase inhibitor in excess of that required to 
inhibit the endogenous cyclic AMP-dependent protein 
kinase completely, magnesium acetate 3.0 mM, and 
[T~~P]ATP 1 .O mM. The stoichiometry of phos- 
phorylation was calculated using an absorbance index, 
Al”/” 
280 nm ’ of 13.4 and a subunit mol. wt 88 000 [s]. 
Electrophoresis and ascending chromatography 
were carried out on thin layer cellulose sheets 
(Eastman no. 13255). Electrophoretic mobilities 
(EM) were expressed relative to aspartic acid at 
pH 6.5 (pyridinelacetic acid/water, 50:2:450) and 
chromatographic mobilities (CM) relative to the 
solvent front (butanol/pyridine/acetic acid/water, 
30:20:6:24). Phosphopeptides were detected by 
staining the sheets with 0.001% fluorescamine or by 
autoradiography, and eluted by extracting the 
cellulose with 1 .O M ammonium hydroxide. Amino 
acid sequences were determined by a microdansyl 
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Edman procedure [S]. Digestion of proteins and 
peptides with proteinases was carried out at 37°C in 
100 mM ammonium bicarbonate. 
3. Results 
3.1. Isolation of tryptic and chymotryptic 
The phosphorylation of glycogen synthase by 
endogenous glycogen synthase kinase-2, reached a
plateau after incubation for about 120 min, at a level 
which was usually in the range 0.3-0.5 molecules of 
phosphate incorporated per subunit. Incubations 
were terminated by addition of 0.1 vol. 100% 
trichloroacetic acid, allowed to stand on ice for 
10 min, and centrifuged at 20 000 X g for 10 min. 
The supernatant was discarded and the precipitate 
was washed twice with 5% trichloroacetic acid and 
twice with water. The precipitate was resuspended at
5 mg/ml in 100 mM ammonium bicarbonate con- 
taining 0.1 mg/ml trypsin ~orthin~on TPCK treated) 
or 0.3 mglml chymotryps~ orthin~on 3X 
crystallised) and digested for 3 h (trypsin) or 6 h 
(chymotrypsin), with occasional shaking. The sus- 
pensions were centrifuged at 20 000 X g for 10 min, 
and the clear supernatant which contained > 95% of 
the 32P radioactivity was lyophilised. The freeze-dried 
material was redissolved in 100 mM ammonium 
bicarbonate and subjected to gel filtration on 
Sephadex G-50 (Pharmacia), equilibrated in the same 
solvent. Typical elution profiles are shown in fig.1 
and 2. A single major peak of 32P radioactivity was 
observed following digestion with either trypsin 
(Y/V, = 1.8) or chymot~psin (y/v0 = 2.0). These peaks 
termed Tl and Cl respectively (fig.1,2) were pooled, 
lyophilised and further purified by ascending 
chromatography. In both cases the major fluorescamine 
Fig.2. Gel filtration of peptide Cl. 32P-Labelled glycogen 
synthase (44 mg) containing 0.45 molecules of phosphate per 
subunit was digested with chymotrypsin and the digest was 
chromatographed on Sephadex G-50 Superfine 
(150 x 1.5 cm) equilibrated in 100 mM NH,HCO,. 
(e---e) 32P radioactivity (Cerenkov counting); (0-o) 
A280 nm. The arrow denotes the position of the void volume, 
yo. The flow rate was 10 ml/h and 2.5 ml fractions were 
coliected. 
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Fig. 1. Gel filtration of peptide Tl . 32 P-Labelled glycogen 
synthase (100 mg) containing 0.33 molecules of phosphate 
per subunit was digested with trypsin and the digest was 
chromatogaphed on Sephadex G-50 Superfine 
(150 X 1.5 cm) equ~~rated in 100 mM NH,HCO,. (O---O) 
3*P radioa~j~ty (Cerenkov count~g); (o-o)A280 nm. The 
arrow denotes the position of the void volume, vo. The flow 
rate was 10 ml/h and 3.8 ml fractions were collected. Frac- 
tions 38-41, which were pooled, corresponded to 33% of the 
radioactivity applied to the column. 
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staining peptide was found to coincide with the 
j2P radioactivity. The peptides were eluted and their 
purity was indicated by the finding of a single 
N-terminal amino acid; threonine in the case of 
peptide Tl, and serine in the case of peptide Cl. The 
amino acid analyses of these peptides are given in 
table 1. The phosphate content of the peptides was 
only about half that of the amino acids present as 
single residues. The most likely explanation for this 
result is that the procedure copurified both the 
phosphorylated and unphosphorylated forms of these 
peptides. The high proportion of hydrophobic amino 
acids is consistent with the chromatographic mobility 
of the peptides and the composition of Cl is 
consistent with the view that it is contained within 
peptide Tl . 
Tl Thr-Leu-Ser-Val-Ser-Ser-Leu 
Cl Ser-Val-Ser-Ser-Ieu-Pro-Gly 
3.2. Location of the phosphoserine 
We have reported that the phenylthiohydantoin 
derivative of phosphoserine is unstable and rapidly 
undergoes hydrolysis to inorganic phosphate [2]. The 
phosphoserine can therefore be located by carrying 
out electrophoresis at pH 6.5, before and after each 
cycle of the Edman degradation. 
Peptide Cl (200 nmol) was digested with 
staphylococcal proteinase (0.1 mg/ml) for 6 h, and 
subjected to electrophoresis at pH 6.5. The single 
32P-labelIed peptide, termed Sl (EM = tO.35), was 
eluted, and its N-terminal sequence was shown to be: 
The dansyl Edman procedure yielded the following 
N-terminal sequences: Ser(P)-Val-Ser-Ser--Leu--Pro-Gly- 
Table 1 
Amino acid compositions of the tryptic and 
chymotryptic phosphopeptides 
Ammo acid Peptide Tl Peptide Cl 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Isoleucine 
Leucine 
Phenylalanine 
Lysine 
Arginine 
Tryptophan 
“*P-phosphate 
5.58 (6) 4.00 (4) 
1.27 (1) 
3.62 (4) 3.81 (4) 
6.25 (6) 4.05 (4) 
1.09 (1) 1.05 (1) 
1.67 (l-2) 1.35 (1) 
2.22 (2) 
3.80 (4) 1.77 (2) 
0.40 
4.99 (5) 4.00 (4) 
2.00 (2) 1.87 (2) 
0.84 (1) 
0.23 
+ (+) + (+) 
0.46 (1) 0.48 (1) 
More than 90% of the radioactivity attached to the 
phosphopeptide was converted to inorganic phosphate 
after the first step of the Edman degradation. Coupled 
with the identification of serine as the first residue, 
this indicated that the N-terminal serine and no other 
residue in the peptide was phosphorylated. The 
sequence of the first six residues of Sl were identical 
to Cl, and the first residue of Cl was also shown to 
be phosphoserine by the same procedure. 
When the peptide Tl was subjected to successive 
Edman degradations, the 32P radioactivity comigrated 
with the fluorescamine-staining peptide material for 
the first two rounds of the Edman degradation, and 
inorganic phosphate appeared only after the third 
cycle. It is therefore concluded that the sequence 
phosphorylated by the endogenous glycogen synthase 
kinase-2 is: 
Total 33-34 23 Thr-Ieu-Ser-(P)-Val-Ser-Ser-Ieu-Pro- 
N-Terminus Thr Ser 
Hydrolyses were carried out in 6 N HCl + 0.01 M phenol for 
20 h, and the analyses were done at 1 10°C on a Beckman 
Multichrom Analyser. Tryptophan was determined by a spot 
test using the Ehrlich reagent. Serine and threonine were 
corrected for 10% and 5% destruction, respectively, and 
valine and isoleucine were corrected assuming the hydrolysis 
of Val-X and Ile-X bonds was only 90% complete. The 
compositions are normalised to leucine, and impurities below 
0.2 mol are omitted 
3.3. The phosphoserine is located at residue 7 from 
the N-terminus of glycogen syn thase 
Following the sequence determination, we noticed 
that the first four residues, Thr-Leu-Ser-Val-, , 
corresponded to residue 5-8 from the N-terminus of 
glycogen synthase reported by Takeda et al. [9] 
suggesting that the phosphoserine might be located at 
residue 7 from the N-terminus of the polypeptide 
chain. However they reported that residue 4 from the 
73 
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N-terminus was serine [9], whereas it would be 
expected to be lysine or arginine, since Tl is a tryptic 
phosphopeptide. The sequence r ported by Takeda 
et al. [9], has been confirmed and extended by Huang 
and Krebs [4] except hat these workers have found 
residue 4 to be arginine and not serlne. Furthermore, 
the phosphopeptide s quence that we have determined 
corresponds exactly to residues 5-13 from the 
N-terminus determined by Huang and Krebs [4]. This 
confirms that the phosphoser~e is indeed located at 
residue 7. The amino acid sequence in this region is 
therefore: 
Pfo-Iau-Ser-Arg-T&--Leu-S&(P)-Val-Ser- 
SE-Leu-Pro--Gly- 
4. Discussion 
The results described here show that the endogenous 
glycogen synthase kinase-2 activity in purified 
glycogen synthase, initially phosphorylates a single 
serine residue which is distinct from both the sites 
phosphorylated by cyclic AMP-dependent protein 
kinase. We suggest that the site phosphorylated by 
glycogen synthase kinase-2 be termed site-Z, and that 
the two sites phosphorylated by cyclic AMP- 
dependent protein kinase be termed site-la and -lb, 
termed site-2 and site-l, respectively in [2]. 
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The finding that site-2 is only seven residues from 
the N-terminus of glycogen synthase, which com- 
prises nearly 800 residues, is of interest since the site 
on glycogen phosphoryla~, phosphorylated by 
phosphorylase kinase is also very close to the 
N-terminus (residue-14 out of 841 residues) [ 121. In 
the following paper we report that glycogen synthase 
kinase-2 activity is strongly stimulated by the 
calcium-dependent regulator protein in the presence 
of calcium ions [lo]. Thus, two protein kinases 
whose activities are activated by calcium ions 
phosphorylate similar egions of their substrate 
proteins. The proximity of site-2 to the N-terminus of 
glycogen synthase should facilitate ~vestigations of 
the phosphory~tion of this site in vivo. 
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